ClinicalTrials.gg
Sign In

Biological

Neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate clinical trials

Also written Menjugate.

studies test it
5
open now
0
in phase 3
1
first study started
2004

How studies write it

Studies that test it under each name

Brand

Menjugate
4

Studies by the year they started

5 studies that test it; most in 2004 (1)

Studies that test neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate, by start year
YearStudies
20041
20051
20081
20111
20131

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
1
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it.

Meningococcal Infections
3
Hepatitis B
1
Infections
1

Who runs them

Industry 2 · Other 3

Public Health England (3) · GlaxoSmithKline (1) · Novartis Vaccines (1)

Often tested with

Tested in the same studies.

Serogroup C meningococcal conjugate vaccine (2) · Haemophilus Vaccines (1) · Meningococcal Vaccines (1) · Hepatitis B virus (1) · Heptavalent Pneumococcal Conjugate Vaccine (1)

Studies

Open first, then newest update. How each study uses neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 1 — neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate is usual care beside what is tested
As the comparator · 13 — what is tested is compared with neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate